Soligenix SNGX
NASDAQ SNGX
$0.36 +0.00 (+0.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Soligenix (SNGX) Long-Term Debt Repayments (2021 - 2025)

Updated

Soligenix's Long-Term Debt Repayments was $1.37 million in FY2025, unchanged from $1.37 million in FY2024.

Analysis

Soligenix (SNGX) Long-Term Debt Repayments (2021 - 2025) Analysis & Trends

From FY2016 onward, Soligenix has reported Long-Term Debt Repayments for 5 years.

  • Long-Term Debt Repayments shows a four-year compound annual growth rate of 286.6% (FY2021 to FY2025).
  • Annual Long-Term Debt Repayments has moved between $6,149 (FY2021) and $7 million (FY2023) over five years.
  • Per Business Quant data, Long-Term Debt Repayments in earlier years was $1.37 million in FY2024 (-80.4%), $7 million in FY2023 and $6,149 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Soligenix 5.74 Mn 5.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.37 Mn
Dec 31, 2024 686,436.00
Sep 30, 2024 432,180.00
Jun 30, 2023 6.00 Mn
Mar 31, 2023 1.00 Mn
Sep 30, 2021 2,101.00
API Access

Soligenix Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SNGX&period=max&api_key=YOUR_API_KEY